Back to Archived Journals » Orphan Drugs: Research and Reviews

Orphan Drugs: Research and Reviews ceased publishing in September 2018 All articles that have been published in Orphan Drugs: Research and Reviews will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Orphan Drugs: Research and Reviews


        

Journal Articles:

- 36 records -

Orphan drugs for the treatment of aspergillosis: focus on isavuconazole

Jacobs SE, Petraitis V, Small CB, Walsh TJ

Orphan Drugs: Research and Reviews 2017乐动体育西班牙人, 7:37-46

Published Date: 3 May 2017

Nitisinone: a review

Aktuglu-Zeybek AC, Zubarioglu T

Orphan Drugs: Research and Reviews 2017, 7:25-35

Published Date: 31 January 2017

Spotlight on anagrelide hydrochloride for the treatment of essential thrombocythemia

Sarma A, Mclornan DP, Harrison CN

Orphan Drugs: Research and Reviews 2017, 7:11-23

Published Date: 31 January 2017

Pompe disease: clinical perspectives

乐动体育西班牙人Cabello JF, Marsden D

Orphan Drugs: Research and Reviews 2017, 7:1-10

Published Date: 28 December 2016

Denosumab in the treatment of hypercalcemia secondary to malignancy

Dalkin AC, Rosner MH

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:113-121

Published Date: 23 November 2015

Orphan drugs for sickle vaso-occlusion: dawn of a new era of targeted treatment

Dampier C

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:99-112

Published Date: 2 November 2015

Orphan drugs in development for primary biliary cirrhosis: challenges and progress

Ali AH, Byrne TJ, Lindor KD

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:83-97

Published Date: 10 September 2015

The efficacy and safety of adalimumab in ocular inflammatory disease

Arcinue CA, Durrani K, Artornsombudh P, Radwan A, Parikh R, Suelves AM, Siddique SS, Chang I, Preble JM, Foster CS

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:69-74

Published Date: 31 August 2015

Profile of lumacaftor/ivacaftor combination: potential in the treatment of cystic fibrosis

乐动体育西班牙人Arends AM, Pettit RS

Orphan Drugs: Research and Reviews 2015, 5:61-68

Published Date: 14 August 2015

Drugs in development and dietary approach for Duchenne muscular dystrophy

Angelini C, Tasca E

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:51-60

Published Date: 11 August 2015

Fahr's disease: current perspectives

Tai XY, Batla A

Orphan Drugs: Research and Reviews 2015, 5:43-49

Published Date: 16 July 2015

Orphan drugs in development for long-chain fatty acid oxidation disorders: challenges and progress

Sun A, Merritt II JL

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:33-41

Published Date: 28 April 2015

Amyotrophic lateral sclerosis: clinical perspectives

Haringer VC, Gibson SB

Orphan Drugs: Research and Reviews 2015乐动体育西班牙人, 5:19-31

Published Date: 15 April 2015

Orphan drugs in glioblastoma multiforme: a review

Lassen U, Mau-Sørensen M, Poulsen HS

Orphan Drugs: Research and Reviews 2014, 4:83-91

Published Date: 14 November 2014

Orphan drugs in development for urea cycle disorders: current perspectives

Häberle J, McCandless SE

Orphan Drugs: Research and Reviews 2014, 4:63-70

Published Date: 30 September 2014

Angiogenesis inhibitors in gastric cancer

McCarthy T, O'Neil BH

Orphan Drugs: Research and Reviews 2014, 4:55-61

Published Date: 14 July 2014

An update on gene therapy for the treatment of lipoprotein lipase deficiency

乐动体育西班牙人Libby AE, Wang H

Orphan Drugs: Research and Reviews 2014, 4:47-54

Published Date: 15 May 2014

Access to cross-border health care services for patients with rare diseases in the European Union

乐动体育西班牙人Aagaard L, Kristensen K

Orphan Drugs: Research and Reviews 2014, 4:39-45

Published Date: 11 April 2014

Stiripentol for the treatment of Dravet syndrome

Chiron C

Orphan Drugs: Research and Reviews 2014, 4:29-38

Published Date: 2 April 2014

Profile of aminopyridines for Lambert–Eaton myasthenic syndrome

Maddison P, Keogh MJ, Sedehizadeh S

Orphan Drugs: Research and Reviews 2014乐动体育西班牙人, 4:11-18

Published Date: 20 January 2014

Do ultra-orphan medicinal products warrant ultra-high prices? A review

Picavet E, Cassiman D, Simoens S

Orphan Drugs: Research and Reviews 2013, 3:23-31

Published Date: 24 June 2013

Tipifarnib and farnesyltransferase inhibitors in the treatment of inflammatory breast cancer: is the story over? A review

Dehghan-Paz I, Il’yasova D, van Golen KL, Usha L

Orphan Drugs: Research and Reviews 2013乐动体育西班牙人, 3:11-21

Published Date: 15 May 2013

Current management options for tyrosinemia

El-Shabrawi MH, Kamal NM

Orphan Drugs: Research and Reviews 2013, 3:1-9

Published Date: 1 March 2013

Wilson’s disease: a review of treatment options with a focus on zinc therapy

乐动体育西班牙人Hui J, Tang NL

Orphan Drugs: Research and Reviews 2012乐动体育西班牙人, 2:35-45

Published Date: 11 October 2012

Prussian blue as an antidote for radioactive thallium and cesium poisoning

乐动体育西班牙人Altagracia-Martinez M, Kravzov-Jinich J, Martínez-Núñez JM, Ríos-Castañeda C, López-Naranjo F

Orphan Drugs: Research and Reviews 2012, 2:13-21

Published Date: 8 June 2012